These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 838632)

  • 1. Microbial reduction of the side-chain carbonyl of daunorubicin and N-acetyldaunorubicin.
    Aszalos AA; Bachur NR; Hamilton BK; Langlykke AF; Roller PP; Sheikh MY; Sutphin MS; Thomas MC; Wareheim DA; Wright LH
    J Antibiot (Tokyo); 1977 Jan; 30(1):50-8. PubMed ID: 838632
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Daunorubicin metabolites in human urine.
    Takanashi S; Bachur NR
    J Pharmacol Exp Ther; 1975 Oct; 195(1):41-9. PubMed ID: 1181403
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microbiol N-acetylation of daunorubicin and daunorubicinol.
    Hamilton BK; Sutphin MS; Thomas MC; Wareheim DA; Aszalos AA
    J Antibiot (Tokyo); 1977 May; 30(5):425-6. PubMed ID: 407204
    [No Abstract]   [Full Text] [Related]  

  • 4. Distribution and metabolism of rubidazone and daunorubicin in mice.
    Baurain R; Deprez-De Campeneere D; Trouet A
    Cancer Chemother Pharmacol; 1979; 2(1):37-41. PubMed ID: 498418
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microbial models for drug metabolism.
    Rosazza JP; Smith RV
    Adv Appl Microbiol; 1979; 25():169-208. PubMed ID: 397736
    [No Abstract]   [Full Text] [Related]  

  • 6. Liquid chromatographic determination of daunorubicin and daunorubicinol in plasma from leukemic patients.
    Eksborg S; Ehrsson H; Andersson B; Beran M
    J Chromatogr; 1978 Jun; 153(1):211-8. PubMed ID: 659557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Daunorubicinol, a major metabolite of daunorubicin: isolation from human urine and enzymatic reactions.
    Bachur NR
    J Pharmacol Exp Ther; 1971 Jun; 177(3):573-8. PubMed ID: 5568811
    [No Abstract]   [Full Text] [Related]  

  • 8. Daunorubicin and daunorubicinol pharmacokinetics in plasma and tissues in the rat.
    Cusack BJ; Young SP; Olson RD
    Cancer Chemother Pharmacol; 1995; 35(3):213-8. PubMed ID: 7805179
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The identification of epsilon-rhodomycinone and 7-deoxy-daunorubicinol aglycone in daunorubicin beers.
    Kern DL; Bunge RH; French JC; Dion HW
    J Antibiot (Tokyo); 1977 May; 30(5):432-4. PubMed ID: 885802
    [No Abstract]   [Full Text] [Related]  

  • 10. Metabolism of the anthracycline antibiotic daunorubicin to daunorubicinol and deoxydaunorubicinol aglycone in hepatocytes isolated from the rat and the rabbit.
    Gewirtz DA; Yanovich S
    Biochem Pharmacol; 1986 Nov; 35(22):4059-64. PubMed ID: 3778526
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stereospecific microbial reduction of 4,5-dihydro-4-(4-methoxyphenyl)-6-(trifluoromethyl-1H-1)-benzazepin+ ++-2-o ne.
    Patel RN; Robison RS; Szarka LJ; Kloss J; Thottathil JK; Mueller RH
    Enzyme Microb Technol; 1991 Nov; 13(11):906-12. PubMed ID: 1368001
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduction of 13-deoxydoxorubicin and daunorubicinol anthraquinones by human carbonyl reductase.
    Slupe A; Williams B; Larson C; Lee LM; Primbs T; Bruesch AJ; Bjorklund C; Warner DL; Peloquin J; Shadle SE; Gambliel HA; Cusack BJ; Olson RD; Charlier HA
    Cardiovasc Toxicol; 2005; 5(4):365-76. PubMed ID: 16382174
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Daunorubicin metabolism: estimation of daunorubicin reductase.
    Bachur NR; Huffman DH
    Br J Pharmacol; 1971 Dec; 43(4):828-33. PubMed ID: 5152029
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determination of daunorubicin and its main metabolites in plasma, urine and leukaemic cells in patients with acute myeloblastic leukaemia.
    Paul C; Baurain R; Gahrton G; Peterson C
    Cancer Lett; 1980 Jun; 9(4):263-9. PubMed ID: 6930988
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enzymatic oxidative activation of 5-iminodaunorubicin. Spectrophotometric and electron paramagnetic resonance studies.
    Kolodziejczyk P; Reszka K; Lown JW
    Biochem Pharmacol; 1989 Mar; 38(5):803-9. PubMed ID: 2539159
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A 13C nuclear magnetic resonance study of N-acetyldaunorubicinol.
    Wright LH; Chan JA; Schroer JA; Aszalos AA
    J Org Chem; 1977 Jun; 42(13):2344-5. PubMed ID: 874611
    [No Abstract]   [Full Text] [Related]  

  • 17. Development of daunorubicin resistance in tumour cells by induction of carbonyl reduction.
    Ax W; Soldan M; Koch L; Maser E
    Biochem Pharmacol; 2000 Feb; 59(3):293-300. PubMed ID: 10609558
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elevated pentose cycle and glucuronyltransferase in daunorubicin-resistant P388 cells.
    Gessner T; Vaughan LA; Beehler BC; Bartels CJ; Baker RM
    Cancer Res; 1990 Jul; 50(13):3921-7. PubMed ID: 2112982
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microbial conversion of daunorubicin into N-acetyl-13(S)-dihydrodaunomycin and bisanhydro-13-dihydrodaunomycinone.
    Dornberger K; Hübener R; Ihn W; Thrum H; Radics L
    J Antibiot (Tokyo); 1985 Sep; 38(9):1219-25. PubMed ID: 4066504
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microbial metabolism of anthracycline antibiotics daunomycin and adriamycin.
    Marshall VP; McGovren JP; Richard FA; Richard RE; Wiley PF
    J Antibiot (Tokyo); 1978 Apr; 31(4):336-42. PubMed ID: 26650
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.